Earlier studies have also reported a high frequency of CD38+HLA-DR+CD8+ T cells in uncomplicated COVID-19 cases (compared to healthy control) and resolved severe cases (compared to severe persistent cases). This evidence concerns the gene CD8A and COVID-19.